Rev-erb-α regulates atrophy-related genes to control skeletal muscle mass

Area of Science:

• Molecular biology
• Metabolism research
• Muscle physiology

Background:

• The nuclear receptor Rev-erb-α (NR1D1) influences metabolism and mitochondrial function in skeletal muscle.
• Previous studies showed Rev-erb-α overexpression or activation enhances mitochondrial respiration and exercise capacity.

Purpose of the Study:

• To investigate the role of Rev-erb-α in regulating skeletal muscle mass.
• To determine if Rev-erb-α can be a pharmacological target for preventing muscle atrophy.

Main Methods:

• Gain- and loss-of-function studies in skeletal muscle.
• Analysis of atrophy-related gene (atrogene) expression.
• In vivo and in vitro experiments.
• Pharmacological activation of Rev-erb-α.

Main Results:

• Rev-erb-α deficiency in skeletal muscle increases atrogene expression, leading to reduced muscle mass and fiber size.
• Overexpression of Rev-erb-α decreases atrogene expression and increases muscle fiber size.
• Pharmacological activation of Rev-erb-α inhibits dexamethasone-induced atrogene upregulation and muscle atrophy.

Conclusions:

• Rev-erb-α is a key regulator of skeletal muscle mass.
• Pharmacological targeting of Rev-erb-α shows promise for preserving muscle mass and combating muscle atrophy.